Similar articles

• Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation.

  Fassett MJ, Wing DA. Fassett MJ, et al. Gynecol Obstet Invest. 2008;65(2):112-5. doi: 10.1159/000109167. Epub 2007 Oct 2. Gynecol Obstet Invest. 2008. PMID: 17912003 Clinical Trial.
• Uterine estrogen receptors are increased by RU486 in late pregnant rhesus macaques but not after spontaneous labor.

  Haluska GJ, West NB, Novy MJ, Brenner RM. Haluska GJ, et al. J Clin Endocrinol Metab. 1990 Jan;70(1):181-6. doi: 10.1210/jcem-70-1-181. J Clin Endocrinol Metab. 1990. PMID: 2294130
• Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II.

  McKeown KJ, Challis JR, Small C, Adamson L, Bocking AD, Fraser M, Rurak D, Riggs KW, Lye SJ. McKeown KJ, et al. Biol Reprod. 2000 Dec;63(6):1899-904. doi: 10.1095/biolreprod63.6.1899. Biol Reprod. 2000. PMID: 11090463
• Uterine contractility and interaction between prostaglandins and antiprogestins. Clinical implications.

  Bygdeman M, Gemzell K, Gottlieb C, Swahn ML. Bygdeman M, et al. Ann N Y Acad Sci. 1991;626:561-7. doi: 10.1111/j.1749-6632.1991.tb37947.x. Ann N Y Acad Sci. 1991. PMID: 2058973 Review.
• Pharmacologic stimulation of uterine contraction.

  Dawood MY. Dawood MY. Semin Perinatol. 1995 Feb;19(1):73-83. doi: 10.1016/s0146-0005(95)80049-2. Semin Perinatol. 1995. PMID: 7754413 Review. No abstract available.